Oncolytic virotherapy with SOCS3 enhances viral replicative potency and oncolysis for gastric cancer

Oncolytic virotherapy is an encouraging treatment using herpes simplex virus (HSV) for gastric cancer patients. To treat gastric cancer, we generated and evaluated the efficacy of an attractive type of oncolytic HSV expressing the suppressor of cytokine signaling 3 (SOCS3). We constructed a third-ge...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsumura, Shuichi, Nakamori, Mikihito, Tsuji, Toshiaki, Kato, Tomoya, Nakamura, Masaki, Ojima, Toshiyasu, Fukuhara, Hiroshi, Ino, Yasushi, Todo, Tomoki, Yamaue, Hiroki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7899552/
https://www.ncbi.nlm.nih.gov/pubmed/33659045
http://dx.doi.org/10.18632/oncotarget.27873

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7899552/
https://www.ncbi.nlm.nih.gov/pubmed/33659045
http://dx.doi.org/10.18632/oncotarget.27873

Ejemplares similares